Option Care Health (NASDAQ:OPCH) Trading Up 5.5% – Here’s Why

Option Care Health, Inc. (NASDAQ:OPCHGet Free Report) shares were up 5.5% during trading on Monday . The stock traded as high as $31.26 and last traded at $31.21. Approximately 875,889 shares were traded during trading, a decline of 37% from the average daily volume of 1,390,514 shares. The stock had previously closed at $29.58.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on OPCH shares. Barrington Research boosted their target price on Option Care Health from $38.00 to $40.00 and gave the stock an “outperform” rating in a research note on Thursday, August 1st. JMP Securities boosted their price target on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th.

Check Out Our Latest Stock Analysis on OPCH

Option Care Health Stock Performance

The stock has a market capitalization of $5.37 billion, a price-to-earnings ratio of 20.14, a P/E/G ratio of 2.21 and a beta of 1.29. The company has a current ratio of 1.76, a quick ratio of 1.36 and a debt-to-equity ratio of 0.78. The firm has a 50-day moving average of $31.00 and a 200-day moving average of $30.15.

Option Care Health (NASDAQ:OPCHGet Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.03. The firm had revenue of $1.23 billion during the quarter, compared to analysts’ expectations of $1.17 billion. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The company’s revenue for the quarter was up 14.8% compared to the same quarter last year. During the same period last year, the business posted $0.63 earnings per share. As a group, sell-side analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Insider Activity

In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares in the company, valued at approximately $663,429.51. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the sale, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

Institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in shares of Option Care Health by 1.6% in the fourth quarter. Vanguard Group Inc. now owns 19,626,205 shares of the company’s stock valued at $661,207,000 after purchasing an additional 306,853 shares during the period. Wellington Management Group LLP raised its holdings in shares of Option Care Health by 157.1% during the fourth quarter. Wellington Management Group LLP now owns 7,445,556 shares of the company’s stock valued at $250,841,000 after acquiring an additional 4,549,164 shares during the last quarter. Thrivent Financial for Lutherans lifted its position in shares of Option Care Health by 9.1% in the second quarter. Thrivent Financial for Lutherans now owns 5,459,119 shares of the company’s stock valued at $151,218,000 after acquiring an additional 455,310 shares in the last quarter. Westfield Capital Management Co. LP boosted its stake in shares of Option Care Health by 15.4% in the first quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock worth $173,448,000 after acquiring an additional 688,653 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its position in shares of Option Care Health by 6.5% during the second quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock worth $99,870,000 after purchasing an additional 218,844 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

About Option Care Health

(Get Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Featured Articles

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.